10
Participants
Start Date
February 1, 2017
Primary Completion Date
June 26, 2019
Study Completion Date
September 30, 2019
avelumab
Avelumab10 mg/kg i.v. at day -7, 7, 21,35 + maintenance therapy i.e avelumab10 mg/kg i.v. every 2 weeks for 6 months
radiotherapy
5 times a week, 7 weeks, total dose 70 Gy
cetuximab
loading dose 400 mg/m2 i.v. day -7, 250 mg/m2 i.v weekly wk 1-7
Antoni van Leeuwenhoek, Amsterdam
Merck KGaA, Darmstadt, Germany
INDUSTRY
The Netherlands Cancer Institute
OTHER